5-Amino-1MQ and metabolic claims: what the research actually shows

A recent TikTok video from Elevate Health is Wealth presents 5-Amino-1MQ as a breakthrough for metabolic health, claiming it supports visceral fat reduction, preserves lean muscle, improves insulin sensitivity, and enhances energy and mental clarity. The caption frames it as “cellular optimization” rather than simple weight loss. But how much of this is backed by peer-reviewed evidence?

What the clip claims

The video lists four primary benefits: visceral fat reduction, lean muscle preservation, improved insulin sensitivity, and better energy/focus. It implies that 5-Amino-1MQ acts as a metabolic switch, making the body burn fat more efficiently. The tone is confident, suggesting these effects are established.

What the research neighborhood actually covers

5-Amino-1MQ is a relatively new compound that has been studied primarily in animal models. The most cited research involves mice, where it was shown to inhibit the enzyme NNMT (nicotinamide N-methyltransferase), leading to increased NAD+ levels and enhanced energy expenditure. In those studies, treated mice gained less weight and showed reduced fat mass, including visceral fat, compared to controls. Some studies also noted improvements in glucose tolerance and insulin sensitivity.

However, these findings are preclinical. No large-scale human clinical trials have been published to date. The leap from rodent metabolism to human physiology is significant, and many compounds that show promise in mice fail to translate. The claim about lean muscle preservation is even less supported—there is minimal direct evidence in any model that 5-Amino-1MQ specifically spares muscle during caloric deficit.

Energy and mental clarity are not measured endpoints in the available studies. These are anecdotal or inferred benefits, likely stemming from the NAD+ connection, but they remain speculative.

Limits of the evidence

The current evidence base is thin. Most studies are short-term, use specific dosages, and are conducted on genetically modified or diet-induced obese mice. There is no consensus on optimal dosing, long-term safety, or efficacy in humans. The peptide is not approved by regulatory agencies for any medical use, and its availability is limited to research settings.

Furthermore, the mechanism—NNMT inhibition—is complex. NNMT is involved in multiple metabolic pathways, and blocking it could have unintended effects. The safety profile in humans is unknown.

Research-use caveat

For researchers, 5-Amino-1MQ is an intriguing tool to study metabolic regulation. But for consumers, the claims made in the video are premature. The phrase “educational information only” does not change the fact that the benefits are not established. Anyone considering this peptide for metabolic health should consult a healthcare provider and rely on clinical evidence, not social media.

Open the full video fact-check page (transcript, takeaways, embedded clip).